Global Diabetes Laboratory Immunoassays Market Companies
- Bayer AG
- Jei Daniel Biotech Corp
- Becton Dickenson
- Acon Laboratories, Inc.
- Beckman Coulter, Inc.
- Immunoshop India Pvt. Ltd.
- Institute of Isotopes Co. Ltd.
- Instrumentation Laboratory Co.
- Abbott Diagnostics
- Qqlab Llc
Recent News:
- In November 2022, LumiraDx Limited, a next generation point-of-care diagnostics company, today announced the continued commercial expansion of its HbA1c test, intended for professional use in a variety of settings health care. Used in conjunction with the LumiraDx platform, this test will monitor the known HbA1c levels of diabetic patients and also serve as an aid in screening and identifying patients who may be at risk of developing diabetes. Providing results in less than seven minutes after sample submission, this test improves efficiency and convenience through on-site diabetes screening and monitoring with the patient.
- In August 2022, Precision Diadia, Inc. announced agreement with DxGen Corp., in the United States to launch Epithod AutoDx, a fully automated point-of-care (POC) analyzer for comprehensive diabetes profiling. Tests. The initial testing list will begin with hemoglobin A1c (A1C), C-reactive protein, and urine albumin, with additional diabetes tests to be added in the near future.